# A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio

> **NCT07745439** · PHASE1 · NOT_YET_RECRUITING · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 18 (estimated)

## Conditions studied

- Healthy Volunteers
- Drug-Drug Interaction (DDI)

## Interventions

- **DRUG:** NTQ5082
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT07745439
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2026-07-30
- **Final completion:** 2027-07-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745439, "A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio". Retrieved via MORVS 2026-10-28 from https://api.morvs.ai/clinical/NCT07745439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*